Investigators sought to determine whether complementary and alternative medicine (CAM) affects survival in female patients with breast cancer.

In this study, investigators aimed to explore outcomes following the development of mental health disorders after cancer diagnosis.

Data show T-DXd improves invasive disease-free survival and reduces the risk of distant recurrence in early HER2-positive breast cancer.

The phase 3 SUCCESSOR-2 trial shows mezigdomide-based therapy improves PFS in R/R multiple myeloma patients previously exposed to lenalidomide.

No increased risk for thrombosis or bleeding seen with concurrent use of enzalutamide, apalutamide, or abiraterone with DOACs ...

Minnesotan immigrants are facing challenges in accessing healthcare for themselves and their children as ICE prevalence has increased.

Investigators sought to determine whether there were gender disparities in opportunities to present original research at the ASCO Annual Meeting.

The BCG strain Tokyo-172 is noninferior to the commonly used TICE strain for relapse-free survival, which could help to alleviate BCG shortages.

For patients with asthma, receipt of immune checkpoint inhibitor (ICI) therapy for melanoma or renal cell carcinoma is not associated with an increased risk for exacerbations, according to a study ...

DBT with supplemental MRI averted 0.1 to 0.8 additional breast cancer deaths across all relative risk levels for women with extremely dense breasts ...

AI use in federal health agencies has been garnering increasing interest due to its potential to expedite processes and improve efficiency.

Investigators evaluated the long-term impact of taxane chemotherapy on patient-reported neuropathy, balance problems, and falls among older breast cancer survivors.